Sponsor
Richard Joseph Durbin
Senator · D-IL
Senator · D-IL
Introduced March 19, 2026 by Richard Joseph Durbin · Last progress March 19, 2026
The bill sharply strengthens protections, transparency, enforcement, and remediation against PFAS contamination — improving public health and environmental outcomes — but does so at the cost of significant compliance, legal, and administrative burdens that could hit small businesses, raise prices, and create transitional regulatory uncertainty.
Consumers and communities (including children and homeowners) will see reduced PFAS exposures as the bill phases out nonessential PFAS in many consumer products, requires bans on detectable releases, and authorizes faster enforcement and cleanup.
State and federal regulators and businesses gain clearer regulatory scope because the bill defines PFAS-related terms and explicitly covers manufacturers, importers, and exporters, improving regulatory certainty for rulemaking and enforcement.
Residents and the public get more transparency and scientific guidance because manufacturers' reports and phaseout plans are publicly posted and the bill requires independent National Academies review and open research from regional Centers of Excellence.
Manufacturers, importers, retailers, and ultimately consumers will face substantial compliance, testing, reformulation, and enforcement costs as many PFAS uses and products are phased out and monitoring/reporting increases.
Small manufacturers and suppliers may lack the technical capacity or capital to develop or procure alternatives within the bill's timelines, risking lost sales, business closures, or market exit.
Centralizing discretionary authority (e.g., EPA defining 'user' and reliance on external statutory lists and National Academies reviews) and long review timelines can create regulatory uncertainty and slow approvals for essential uses and industry planning.
Based on analysis of 4 sections of legislative text.
Directs EPA to use a National Academies review to define essential PFAS uses, phase out nonessential uses, authorizes enforcement (civil and criminal), and establishes two Centers of Excellence for PFAS science and remediation.
Requires the EPA to use a multi-year National Academies review to decide which uses of PFAS (per- and polyfluoroalkyl substances) are "essential" and to prioritize phasing out nonessential uses; gives EPA authority to order suspensions, seek civil and criminal penalties for violations, and establishes two university-based Centers of Excellence to advance PFAS detection, remediation, and safer alternatives. It creates detailed definitions for manufacturers, users, essential and nonessential uses, and sets timelines for the scientific review and implementation steps.